BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1244@pharmaconomics
DTSTAMP:20260707T015755Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:ABVX Approval — obefazimod (estimated date)
DESCRIPTION:A final FDA approval decision on obefazimod for ulcerative colitis is expected ~ Dec 31\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1956827/000119312526252360/d98688d6k.htm\n\nTrack it: https://pharmaconomics.com/e/1244
URL:https://pharmaconomics.com/e/1244
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ABVX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR